PO-1697: Radiotherapy for prostate cancer: Effects of fiducial gold marker on diffusion-weighted MR imaging. (November 2020) - Tanaka, O.; Maejima, R.; Taniguchi, T.; Ono, K.; Makita, C.; Yama, E.; Matsuo, M.